MedGenome, headquartered in California, delivers cutting-edge multiomics solutions, focusing on next-generation sequencing, single-cell sequencing, and antibody discovery. Operating in the US, India, and Singapore, MedGenome advances global research in precision medicine, tackling healthcare disparities. As a founding member of GenomeAsia 100K, they contribute significantly to genomic data research and biomarker discovery.